Abstract:Background: Histopathological examination, a cornerstone in diagnosing cancer, faces challenges due to its time-consuming nature. This review explores the potential of ex-vivo fluorescent confocal microscopy (FCM) in urology, addressing the need for real-time pathological assessment, particularly in prostate cancer. This systematic review aims to assess the applications of FCM in urology, including its role in prostate cancer diagnosis, surgical margin assessment, and other urological fields. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, a systematic search of PubMed and SCOPUS was conducted, focusing on English written original articles published after January 1, 2018, discussing the use of FCM in urological practice. The search included keywords related to FCM and urological terms. The risk of bias assessment was performed using Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Results: A total of 17 relevant studies were included in the review that focuses on three main urological issues: prostate cancer (15 articles), bladder cancer (1 article), and renal biopsy (1 article). FCM exhibited significant promise in diagnosing prostate cancer. These studies reported an accuracy range of 85.33% to 95.1% in distinguishing between cancerous and non-cancerous prostate tissues. Moreover, FCM proved valuable for assessing surgical margins in real-time during radical prostatectomy, reducing the need for frozen section analysis. In some investigations, researchers explored the integration of artificial intelligence (AI) with FCM to automate diagnostic processes. Concerning bladder cancer, FCM played a beneficial role in evaluating urethral and ureteral margins during radical cystectomy. Notably, it showed substantial agreement with conventional histopathology and frozen section examination. In the context of renal biopsy, FCM demonstrated the potential to differentiate normal renal parenchyma from cancerous tissue, although the available evidence is limited in this area. The main limitation of the current study is the scarcity of data regarding the topic of interest. Conclusions: Ex-vivo FCM holds promise in urology, particularly in prostate cancer diagnosis and surgical margin assessment. Its real-time capabilities may reduce diagnostic delays and patient stress. However, most studies remain experimental, requiring further research to validate clinical utility.

Omics in urology: An overview on concepts, current status and future perspectives

[Current applications and translational prospects of omics technologies in urothelial carcinoma]

Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology

PIONEERING ADVANCEMENTS IN UROLOGY: ARTIFICIAL INTELLIGENCE, GENOMIC INSIGHTS, NOVEL TREATMENTS, DIAGNOSTICS, AND TARGETED THERAPIES TRANSFORMING PATIENT CARE

Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer

Molecular pathology of urothelial carcinoma

Applying Multi-Omics Toward Tumor Microbiome Research

Predictive and prognostic biomarkers in urological tumours

Omics sciences and precision medicine in colon cancer

Microbiome in urologic neoplasms: focusing on tumor immunity

Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification

Proteomics and peptidomics: moving toward precision medicine in urological malignancies

The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers

The emerging role of the urinary microbiome in benign noninfectious urological conditions: an up-to-date systematic review

Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology

Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology

Current applications of ex-vivo fluorescent confocal microscope in urological practice: a systematic review of literature

Transforming Clinical Research: The Power of High-Throughput Omics Integration

Nanotechnology in Urology

From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine

Understanding the Conundrum of Pancreatic Cancer in the Omics Sciences Era